Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Unlocking the diagnostic power of plasma extracellular vesicle miR-200 family in pancreatic ductal adenocarcinoma

ABSTRACT: Unlocking the diagnostic power of plasma extracellular vesicle miR-200 family in pancreatic ductal adenocarcinoma

PROVIDER: PRJNA1295492 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Similar Datasets

Unlocking the diagnostic power of plasma extracellular vesicle miR-200 family in pancreatic ductal adenocarcinoma

Project description:Background Distinguishing benign from malignant pancreaticobiliary disease is challenging because of the absence of reliable biomarkers. Circulating extracellular vesicles (EVs) have emerged as functional mediators between cells. Their cargos, including microRNAs (miRNAs), are increasingly acknowledged as an important source of potential biomarkers. This multicentric, prospective study aimed to establish a diagnostic plasma EV-derived miRNA signature to discriminate pancreatic ductal adenocarcinoma (PDAC) from benign pancreaticobiliary disease. Methods Plasma EVs were isolated using size exclusion chromatography (SEC) and characterised using nanoparticle tracking analysis, electron microscopy and Western blotting. EV-RNAs underwent small RNA sequencing to discover differentially expressed markers for PDAC (n = 10 benign vs. 10 PDAC). Candidate EV-miRNAs were then validated in a cohort of 61 patients (n = 31 benign vs. 30 PDAC) by RT-qPCR. Logistic regression and optimal thresholds (Youden Index) were used to develop an EV-miR-200 family model to detect cancer. This model was tested in an independent cohort of 95 patients (n = 30 benign, 33 PDAC, and 32 cholangiocarcinoma). Results Small RNA sequencing and RT-qPCR showed that EV-miR-200 family members were significantly overexpressed in PDAC vs. benign disease. Combined expression of the EV-miR-200 family showed an AUC of 0.823. In an independent validation cohort, application of this model showed a sensitivity, specificity and AUC of 100%, 88%, and 0.97, respectively, for diagnosing PDAC.

2025-07-31 | GSE303476 | GEO

Unlocking the power of transcriptomic biomarkers in qualitative and quantitative genotoxicity assessment of chemicals

Project description:Unlocking the power of transcriptomic biomarkers in qualitative and quantitative genotoxicity assessment of chemicals

| PRJNA1006340 | ENA

Unlocking the power of transcriptomic biomarkers in qualitative and quantitative genotoxicity assessment of chemicals I

Project description:Unlocking the power of transcriptomic biomarkers in qualitative and quantitative genotoxicity assessment of chemicals I

| PRJNA1006335 | ENA

Unlocking the power of transcriptomic biomarkers in qualitative and quantitative genotoxicity assessment of chemicals II

Project description:Unlocking the power of transcriptomic biomarkers in qualitative and quantitative genotoxicity assessment of chemicals II

| PRJNA1006345 | ENA

power plant metagenome

Project description:power plant metagenome Raw sequence reads

| PRJNA407460 | ENA

Sinorhizobium meliloti strain:200

Project description:Sinorhizobium meliloti 200 Resequencing

| PRJNA501489 | ENA

Circulating extracellular vesicle-derived microRNAs as novel diagnostic and prognostic biomarkers for non-viral-related hepatocellular carcinoma

Project description:The potential significance of plasma extracellular vesicle-derived miRNAs in non-hepatitis B-, non-hepatitis C-related hepatocellular carcinoma as biomarker for the diseases was explored.

2023-10-11 | GSE244605 | GEO

Clostridium saccharobutylicum strain:NCP 200

Project description:Clostridium saccharobutylicum NCP 200

| PRJNA322799 | ENA

Pseudooceanicola sp. 200-1SW

Project description:Pseudooceanicola sp. 200-1SW Genome sequencing

| PRJNA1268177 | ENA

Thermoanaerobacter ethanolicus JW 200

Project description:Thermoanaerobacter ethanolicus JW 200 genome sequencing

| PRJNA51151 | ENA